Neuro-protective and Neuro-generative Archives - Purablis-Medicinal Tinctures with CBD, THCA and THC

Neuro-protective and Neuro-generative Marijuana Studies and

Neuro-protective and Neuro-generative Cannabis Research

09/28/2018

Author(s): Alline C. Campos, Manoela V. Fogac, Andreza B. Sonegoa, Francisco S. Guimarães.

The neuroprotective properties of cannabidiol seem to depend on several cannabinoid-dependent and independent mechanisms. Preclinical evidence clearly indicate that cannabidiol represents a new opportunity for the treatment of several brain disorders (such as neurodegenerative and neuropsychiatric) where neuronal loss or damage plays a significant role. View study

09/28/2018

Author(s): Kozela E , Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben­Nun A, Juknat A, Vogel Z.

The cannabidiol (CBD) is, potentially, a safe and effective alternative for alleviating neuroinflammation and neurodegeneration. CBD ameliorates clinical signs of experimental autoimmune encephalomyelitis in mice, immunized against myelin oligodendrocyte glycoprotein. Suppression of microglial activity and T­cell proliferation by CBD appeared to contribute to these beneficial effects. View study

09/28/2018

Author(s): .

A promising hope lies in the therapeutic potential of cannabinoids as neuroprotective against neurodegenerative disorders such as chronic Parkinson’s or Huntington’s diseases. View study

09/28/2018

Author(s): Javier Fernández-Ruiz1,2,3 & María A. Moro4,5 & José Martínez-Orgado6.

This study states that cannabinoid-based drugs can serve as a new therapy capable of delaying / stopping neurodegeneration in acute and chronic neurodegenerative conditions. View study

09/28/2018

Author(s): Gareth Pryce,1* Zubair Ahmed,1* Deborah J. R. Hankey,1* Samuel J. Jackson,1 J. Ludovic Croxford,1 Jennifer M. Pocock,1 Catherine Ledent,2 Axel Petzold,1 Alan J. Thompson,3 Gavin Giovannoni,1 M. Louise Cuzner1 and David Baker1.

The therapeutic use of cannabis could alleviate symptoms and delay neurodegenerative processes in multiple sclerosis and other diseases. View study

09/28/2018

Author(s): Giovanni Marsicano,1 * Sharon Goodenough,2,4* Krisztina Monory,1 * Heike Hermann,1 Matthias Eder,3 Astrid Cannich,1 Shahnaz C. Azad,3,5 Maria Grazia Cascio,6 Silvia Ortega Gutie´rrez,7 Mario van der Stelt,6 Maria Luz Lo´pez-Rodrı´guez,7 Emilio Casanova,8 Gu¨nther Schu¨tz,8 Walter Zieglga¨nsberger,3 Vincenzo Di Marzo,6 Christian Behl,2,4† Beat Lutz.

The endogenous cannabinoid system provides on-demand protection against acute excitotoxicity in neurons of the central nervous system. View study

09/28/2018

Author(s): Anke Witting*, Lanfen Chen†‡, Eiron Cudaback*‡, Alex Straiker§, Lisa Walter*¶, Barry Rickman , Thomas Mo¨ ller†**, Celia Brosnan†, and Nephi Stella*††‡‡§§.

Through experimental methods, these studies suggest the potential of cannabinoids in the development of neuroprotective drugs for the treatment of multiple sclerosis. View study

09/28/2018

Author(s): Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben­Nun A, Juknat A, Vogel Z.

The cannabidiol (CBD) is, potentially, a safe and effective alternative for alleviating neuroinflammation and neurodegeneration. CBD ameliorates clinical signs of experimental autoimmune encephalomyelitis in mice, immunized against myelin oligodendrocyte glycoprotein. Suppression of microglial activity and T­cell proliferation by CBD appeared to contribute to these beneficial effects. View study

09/28/2018

Author(s): Susanne A Wolf, Anika Bick-Sander, Klaus Fabel, Perla Leal-Galicia, Svantje Tauber, Gerardo RamirezRodriguez, Anke Müller, Andre Melnik, Tim P Waltinger, Oliver Ullrich and Gerd Kempermann.

This study states that some of the positive therapeutic characteristics of CBD-based compounds could be explained by the pro-neurogenic effects of CBD. View study

09/28/2018

Author(s): Onintza Sagredo . Moisés García-Arencibia Eva de Lago – Simone Finetti Alessandra Decio Javier Fernández-Ruiz.

A promising hope lies in the therapeutic potential of cannabinoids as neuroprotective against neurodegenerative disorders such as chronic Parkinson’s or Huntington’s diseases. View study

09/28/2018

Author(s): Javier Fernández-Ruiz, & María A. Moro, & José Martínez-Orgado.

This study states that cannabinoid-based drugs can serve as a new therapy capable of delaying / stopping neurodegeneration in acute and chronic neurodegenerative conditions. View study

09/28/2018

Author(s): Carol Hamelink, Aidan Hampson, David A. Wink, Lee E. Eiden, and Robert L. Eskay.

Cannabidiol (CBD) was evaluated as a neuroprotector in a borage model of ethanol. When administered at the same time as excessive exposure to ethanol, CBD protects against hippocampal and entorhinal cortical neurodegeneration in a dose-dependent manner. This study provides the first demonstration of CBD as a neuroprotective in vivo and shows the efficacy of lipophilic antioxidants in the prevention of brain lesions induced by excess ethanol. View study